$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2017-04-10 AccNo: 0001193125-17-117256 Size: 16 KBItem 8.01: Other Events 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2017-04-05 AccNo: 0001564590-17-006077 Size: 43 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$赛托瑞疗法(CYTX)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2017-03-31 AccNo: 0001564590-17-005826 Size: 894 KB 网页链接
$赛托瑞疗法(CYTX)$ EFFECT - Notice of Effectiveness Filed: 2017-03-30 AccNo: 9999999995-17-000698 Size: 1 KB 网页链接
$赛托瑞疗法(CYTX)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2017-03-27 AccNo: 0001564590-17-005267 Size: 637 KB 网页链接
$赛托瑞疗法(CYTX)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2017-03-24 AccNo: 0001564590-17-005251 Size: 14 MB 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2017-03-23 AccNo: 0001564590-17-005152 Size: 686 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2017-03-23 AccNo: 0001564590-17-005152 Size: 686 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$赛托瑞疗法(CYTX)$ 美东时间 2017-03-23 盘后 披露财报,预期EPS -0.26 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2017-03-03 AccNo: 0001564590-17-003336 Size: 39 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接